Tag: financials

  • JT Reports Record Year with Revenue Up 13%

    JT Reports Record Year with Revenue Up 13%

    Japan Tobacco Inc. (JT) reported record fiscal 2025 results, with revenue rising 13.4% to JPY 3.47 trillion ($22.6 billion) and adjusted operating profit increasing 21.5% to JPY 902.2 billion ($5.9 billion), driven largely by tobacco business growth and the acquisition of Vector Group. Profit climbed 188.9% to JPY 499.1 billion ($3.2 billion), while free cash flow rose to JPY 272.7 billion ($1.8 billion), and the company plans to pay an annual dividend of JPY 234 ($1.52) per share.

    For fiscal 2026, JT forecasts continued growth, projecting revenue to increase 6.6% and adjusted operating profit to rise 7.9%, as it accelerates investment in heated tobacco products to complement its combustible cigarette portfolio and support long-term earnings expansion.

    “These achievements are the outcome of the strategic investments we have actively pursued over the years,” said JT Group president and CEO Takehiko Tsutsui. “In our Business Plan 2026, we intend to accelerate investments in heated products with the aim of establishing them as the second pillar of profit growth, alongside combustibles, in future years. Furthermore, we are targeting high single digit growth at a [compound annual growth rate] in consolidated adjusted operating profit at constant FX, driven by the tobacco business.”

  • Pyxus Reports Strong 3Q Results

    Pyxus Reports Strong 3Q Results

    Pyxus International reported third-quarter fiscal 2026 net income of $16.9 million, with adjusted EBITDA holding steady at $80 million, as increased shipping volumes and third-party processing offset lower leaf product revenues. Quarterly sales fell to $655.8 million from $778.3 million a year earlier, largely due to shipment timing and lower average pricing in South America. The company reaffirmed full-year guidance of $2.4 billion to $2.6 billion in net sales and $215 million to $235 million in adjusted EBITDA, while warning that strong global crop production could lead to oversupply heading into fiscal 2027.

    Tobacco inventory at the end of the third quarter was $959.8 million, compared to $755.2 million at the same time last year, reflecting procurement of the larger current crops. Uncommitted inventory as a percentage of total processed tobacco remains unchanged from the prior year. At December 31, 2025, uncommitted inventory was $28 million, or 3.6%, of the $768.6 million in total processed inventory, compared to $21.9 million, or 3.6%, of total processed inventory of $603.3 million at December 31, 2024.

  • Universal Posts Nine-Month, Q3 Results

    Universal Posts Nine-Month, Q3 Results

    Universal Corporation reported “solid results” for the nine months and third quarter ended December 31, 2025, supported by continued strength in its tobacco operations despite softer overall volumes and headwinds in its ingredients business. Nine-month revenue declined 2% to $2.2 billion, and operating income fell 3% to $183 million, reflecting lower tobacco sales volumes and higher fixed costs, although customer demand for most tobacco styles remained firm and third-party processing volumes increased. Third-quarter revenue dropped 8% to $861 million, with operating income down 21% to $82 million, driven by reduced tobacco shipments and inventory write-downs, while the ingredients segment faced tariff pressures, weaker consumer-packaged-goods demand, and higher depreciation costs. The company also strengthened liquidity through a refinancing and expansion of its revolving credit facility and highlighted sustainability progress, including a significant increase in renewable electricity use and continued farmer engagement across its global supply chain.

  • PMI Reports $40B in Revenue, Including 42% from Smoke-Free Products

    PMI Reports $40B in Revenue, Including 42% from Smoke-Free Products

    Philip Morris International reported strong 2025 fourth-quarter and full-year results, driven largely by the continued expansion of its smoke-free product portfolio. The company recorded more than $40 billion in annual net revenues, including nearly $17 billion from smoke-free products, which accounted for 41.5% of total net revenues. Smoke-free shipment volumes rose 12.8% for the year, with PMI’s products now available in 106 markets and used by an estimated 43 million adult consumers. IQOS maintained a dominant position in heat-not-burn, holding about 76% global category share, while nicotine pouch brand Zyn continued rapid growth, particularly in the U.S., where shipment volumes reached 794 million cans for the year.

    PMI’s combustible business remained stable despite expected volume declines, supported by pricing strength and productivity improvements. Marlboro reached a record 11% global category share, while total company shipment volumes remained flat as growth in smoke-free products offset cigarette declines. The company also reported strong performance across multiple regions, including double-digit heated tobacco growth in Europe and sustained category leadership in Japan, where heat-not-burn products now exceed 50% of total nicotine offtake in several major markets.

    Looking ahead, PMI expects continued momentum, forecasting 2026 adjusted diluted EPS growth of 7.5% to 9.5% excluding currency effects. The company also introduced 2026–2028 targets calling for 6% to 8% organic net revenue growth and 9% to 11% adjusted EPS growth, driven primarily by high single-digit to low-teens expansion in smoke-free product volumes.

    In response to the financials, Morgan Stanley said it expects a modest negative market reaction to PMI’s fourth-quarter results and forward guidance, which were largely in line with expectations following the stock’s strong rally since December.

    “On balance, 4Q results were broadly in line, and guidance looks reasonable, but is unlikely to settle the debate around the stock,” Morgan Stanley wrote. “Bears continue to point to a 2H-weighted year with headwinds from IQOS competition and excise tax increases in Japan, the flavor ban in Poland, and continued competition in U.S. nicotine pouches. Bulls point to PM delivering the best mid-term growth in large-cap CPG despite these known headwinds. We are [rating the stock] Overweight, and continue to expect growth to reaccelerate in 2H as these headwinds dissipate, and for US Zyn trends to improve with the likely FDA authorization of Zyn Ultra.”

  • Universal Announces Quarterly Dividend

    Universal Announces Quarterly Dividend

    Universal Corporation announced its board of directors has declared a quarterly dividend of $0.82 per share, payable May 4, to shareholders of record as of April 15. The company, operating across more than 30 countries, said the dividend reflects its ongoing shareholder return strategy. Universal has more than a century of experience supplying agricultural products through an international network of farmers and partners, supported by integrated processing capabilities and sustainability-focused supply chain operations.

  • KT&G Reports Record Numbers on 10% Growth

    KT&G Reports Record Numbers on 10% Growth

    KT&G reported record financial performance for 2025, with fourth-quarter consolidated revenue rising 10.1% year over year to KRW 1.7 trillion ($1.2 billion) and operating profit increasing 17.1% to KRW 248.8 billion ($169.2 million). In financials released today (Feb. 5), the company said full-year revenue grew 11.4% to a record KRW 6.58 trillion ($4.5 billion), while operating profit climbed 13.5% to KRW 1.4 trillion ($918 million), or KRW 1.4 trillion ($965.6 million) on an adjusted basis excluding one-time labor costs. The company attributed the results to structural reforms and global competitiveness initiatives implemented under CEO Kyung-man Bang, with its global cigarette business delivering record revenue, volume, and operating profit. International cigarette revenue rose 14.6% to KRW 1.9 trillion ($1.3 billion) and, for the first time, accounted for 54.1% of total cigarette revenue, supported by volume growth and strategic pricing actions.

    KT&G’s next-generation product (NGP) segment also expanded, with revenue increasing 13.5% to KRW 890.1 billion ($605 million) and stick volumes reaching 14.8 billion units. The company signaled a broader NGP strategy beyond heated tobacco, including portfolio diversification into nicotine pouches following its acquisition of Another Snus Factory. Management emphasized that NGP expansion is intended to complement core combustible operations while strengthening long-term tobacco category competitiveness across domestic and international markets.

    Looking ahead, KT&G outlined 2026 growth targets supported by a KRW 2.4 trillion ($1.6 billion) capital investment program aimed at expanding global manufacturing capacity, including new facilities in Kazakhstan and Indonesia. The company expects these investments to support cost reductions, pricing optimization, and business model diversification through OEM and licensing partnerships. KT&G is targeting revenue growth of 3% to 5% and operating profit growth of 6% to 8% while maintaining a total shareholder return of at least 100%, supported by a dividend payout ratio of 50% or higher and potential share repurchases.

  • Universal Announces 3Q Conference Call

    Universal Announces 3Q Conference Call

    Universal Corporation announced it will release results for its fiscal third quarter 2026 before market open on February 9, followed by a conference call and webcast at 5 p.m. ET. The company will host the call in listen-only format via its website, with a replay available online through May 9, and by phone through February 23.

  • PMI to Host Q4 and FY25 Webcast February 6

    PMI to Host Q4 and FY25 Webcast February 6

    Philip Morris International said it will host a live audio webcast on February 6 at 9 a.m. ET to discuss its fourth-quarter and full-year 2025 financial results, which are scheduled to be released two hours prior. The listen-only webcast will be hosted by Group CEO Jacek Olczak and CFO Emmanuel Babeau and will include a presentation of results followed by a Q&A session with investors. A recording, slides, and transcript will be available after the event for one year, and the webcast can also be accessed through PMI’s Investor Relations mobile app.

  • Scandinavian Narrows 2025 Outlook After Steady Q3 Performance

    Scandinavian Narrows 2025 Outlook After Steady Q3 Performance

    For the first nine months of 2025, Scandinavian Tobacco Group A/S (STG) reported net sales of DKK 6.7 billion ($1.1 billion), EBITDA margin of 19.9%, and free cash flow before acquisitions of DKK 448 million ($71.2 million), up from DKK 327 million ($52.3 million) a year earlier. STG reported third-quarter 2025 net sales of DKK 2.4 billion ($384 million), with organic growth flat year-on-year and EBITDA before special items at DKK 519 million ($83million), reflecting a 22% margin versus 23.4% last year.

    The company said results were broadly in line with expectations, though exchange rate pressures weighed on reported sales. Growth was recorded in Handmade Cigars and Next Generation Products, offset by declines in Machine-Rolled Cigars and Smoking Tobacco. CEO Niels Frederiksen noted that while market conditions remain challenging, the group saw stabilization in handmade cigars and growth in nicotine pouches. However, market share in machine-rolled cigars was affected by the rollout of STG’s new global SAP system.

    The company narrowed its full-year guidance to reflect better visibility heading into year-end and the effect of USD movements. STG plans to unveil its next five-year strategy on November 20, outlining growth priorities and stakeholder value initiatives.

  • Pyxus International to Report Q2 FY2026 Results November 12

    Pyxus International to Report Q2 FY2026 Results November 12

    Pyxus International, Inc. said it will release its second-quarter fiscal 2026 financial results November 12, before market open. The company will host an earnings call and webcast at 9 a.m. EST to discuss the results.

    Those interested can call +1 (646) 769-9200 or (800) 330-6710 with conference ID 2153372, or access the live webcast via Pyxus’ investor relations webpage. A press release and Q2 presentation will be available prior to the call. An archived recording will be posted shortly after the call.